Drug Type Small molecule drug |
Synonyms Centyl K |
Target |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date SE (17 Sep 2010), |
Regulation- |
Molecular FormulaC15H14F3N3O4S2 |
InChIKeyHDWIHXWEUNVBIY-UHFFFAOYSA-N |
CAS Registry73-48-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Edema | SE | 17 Sep 2010 | |
Hypertension | SE | 17 Sep 2010 | |
Nephrolithiasis | SE | 17 Sep 2010 |